Peter Chase

2.6k citations

69 papers · 2.1k · h-index 24

Impact in

Physiology top 2%
Molecular Biology top 10%
- Receptor Mechanisms and Signaling
- Ubiquitin and proteasome pathways

Papers in

Molecular Biology 46
- Receptor Mechanisms and Signaling 19
- Sphingolipid Metabolism and Signaling 5
- Ubiquitin and proteasome pathways 4
Cellular and Molecular Neuroscience 14
- Neuropeptides and Animal Physiology 8
- Neuroscience and Neuropharmacology Research 7

Co-authors: Peter Hodder (53 shared papers)Timothy Spicer (24 shared papers)Franck Madoux (18 shared papers)Hugh Rosen (14 shared papers)S. Adrian Saldanha (7 shared papers)Dmitriy Minond (4 shared papers)Craig W. Lindsley (11 shared papers)Patrick R. Griffin (6 shared papers)
Journals: SLAS DISCOVERY (13 papers)Bioorganic & Medicinal Chemistry Letters (9 papers)Assay and Drug Development Technologies (5 papers)ACS Chemical Biology (4 papers)Journal of Medicinal Chemistry (3 papers)
Partner nations: United States Australia Canada

In The Last Decade

Peter Chase

67 papers receiving 2.1k citations

Peers

Countries citing papers authored by Peter Chase

Since Specialization

Citations

This map shows the geographic impact of Peter Chase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Chase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Chase more than expected).

Fields of papers citing papers by Peter Chase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Chase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Chase. The network helps show where Peter Chase may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Chase, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Chase Line = papers co-authored together Peter Chase links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways Proceedings of the National Academy of Sciences ·Tsui‐Fen Chou, Steve Brown, Dmitriy Minond, Brian E. Nordin, Kelin Li, Amanda C. Jones, Peter Chase, Patrick Porubsky, Brian M. Stoltz, Frank J. Schoenen, Matthew P. Patricelli, Peter Hodder, Hugh Rosen, Raymond J. Deshaies	2011	267
2	Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease Journal of Medicinal Chemistry ·Jon Jacobs, Valerie Grum‐Tokars, Ya Zhou, Mark Turlington, S. Adrian Saldanha, Peter Chase, Aimee L. Eggler, Eric S. Dawson, Yahira M. Báez-Santos, Sakshi Tomar, Anna M. Mielech, Susan C. Baker, Craig W. Lindsley, Peter Hodder, Andrew D. Mesecar, Shaun R. Stauffer	2012	162
3	Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1 Cancer Research ·Ying Wang, David M. Lonard, Yang Yu, Dar‐Chone Chow, Timothy Palzkill, Jin Wang, Ruogu Qi, Alexander J. Matzuk, Xianzhou Song, Franck Madoux, Peter Hodder, Peter Chase, Patrick R. Griffin, Suoling Zhou, Lan Liao, Jianming Xu, Bert W. O’Malley	2014	152
4	Small Molecule Activators of TRPML3 Chemistry & Biology ·Christian Grimm, Simone Jörs, S. Adrian Saldanha, Alexander G. Obukhov, Bifeng Pan, Kazuo Oshima, Math P. Cuajungco, Peter Chase, Peter Hodder, Stefan Heller	2010	106
5	Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding Bioorganic & Medicinal Chemistry Letters ·Mark Turlington, Aspen Chun, Sakshi Tomar, Aimee L. Eggler, Valerie Grum‐Tokars, Jon Jacobs, J. Scott Daniels, Eric S. Dawson, Adrian Saldanha, Peter Chase, Yahira M. Báez-Santos, Craig W. Lindsley, Peter Hodder, Andrew D. Mesecar, Shaun R. Stauffer	2013	101
6	Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle Cell Metabolism ·Matthew A. Sanders, Franck Madoux, Ljiljana Mladenovic, Huamei Zhang, Xiangqun Ye, Michelle Angrish, Emilio P. Mottillo, Joseph A. Caruso, Geoff T. Halvorsen, William Roush, Peter Chase, Peter Hodder, James G. Granneman	2015	94
7	Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors Proceedings of the National Academy of Sciences ·Daniel A. Bachovchin, Justin T. Mohr, Anna E Speers, Chu Wang, Jacob M. Berlin, Timothy Spicer, Virneliz Fernández-Vega, Peter Chase, Peter Hodder, Stephan C. Schürer, Daniel K. Nomura, Hugh Rosen, Gregory C. Fu, Benjamin F. Cravatt	2011	92
8	Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle Metabolism ·Marc E. Tischler, Sara B. Rosenberg, Soisungwan Satarug, Erik J. Henriksen, C. R. Kirby, Margaret E. Tome, Peter Chase	1990	85
9	Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents Proceedings of the National Academy of Sciences ·Yervand E Karapetyan, Gian Franco Sferrazza, Minghai Zhou, Gregory Ottenberg, Timothy Spicer, Peter Chase, Mohammad Fallahi, Peter Hodder, Charles Weissmann, Corinne Ida Lasmézas	2013	79
10	Discovery of the First M₅-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375) Journal of Medicinal Chemistry ·Patrick R. Gentry, Masaya Kokubo, Thomas M. Bridges, Nathan R. Kett, Joel M. Harp, Hyekyung P. Cho, Emery Smith, Peter Chase, Peter Hodder, Colleen M. Niswender, J. Scott Daniels, P. Jeffrey Conn, Michael R. Wood, Craig W. Lindsley	2013	59
11	Selective and Brain Penetrant Neuropeptide Y Y2 Receptor Antagonists Discovered by Whole-Cell High-Throughput Screening Molecular Pharmacology ·Shaun P. Brothers, S. Adrian Saldanha, Timothy Spicer, Michael D. Cameron, Becky A. Mercer, Peter Chase, Patricia McDonald, Claes Wahlestedt, Peter Hodder	2009	52
12	High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate Bioorganic & Medicinal Chemistry ·Janelle L. Lauer‐Fields, Dmitriy Minond, Peter Chase, Pierre Baillargeon, S. Adrian Saldanha, Roma Stawikowska, Peter Hodder, Gregg B. Fields	2008	50
13	Ligand-Binding Pocket Shape Differences between Sphingosine 1-Phosphate (S1P) Receptors S1P₁ and S1P₃ Determine Efficiency of Chemical Probe Identification by Ultrahigh-Throughput Screening ACS Chemical Biology ·Stephan C. Schürer, Steven J Brown, Pedro J. Gonzalez‐Cabrera, Marie-Therese Schaeffer, Jacqueline V. Chapman, Euijung Jo, Peter Chase, Tim Spicer, Peter Hodder, Hugh Rosen	2008	48
14	Potent, Selective and Cell Penetrant Inhibitors of SF-1 by Functional Ultra-High-Throughput Screening Molecular Pharmacology ·Franck Madoux, Xiaolin Li, Peter Chase, Gina Zastrow, Michael D. Cameron, Juliana J. Conkright, Patrick R. Griffin, Scott M. Thacher, Peter Hodder	2008	44
15	Comparison of Miniaturized Time-Resolved Fluorescence Resonance Energy Transfer and Enzyme-Coupled Luciferase High-Throughput Screening Assays to Discover Inhibitors of Rho-Kinase II (ROCK-II) SLAS DISCOVERY ·Thomas Schröter, Dmitriy Minond, Amiee Weiser, Chinh T. Dao, Jeff E. Habel, Timothy Spicer, Peter Chase, Pierre Baillargeon, Louis Scampavia, Stephan C. Schürer, Caty Chung, Chris Mader, Mark R. Southern, Nick Tsinoremas, Philip V. LoGrasso, Peter Hodder	2008	42
16	Identification of Small-Molecule Inhibitors of the Colorectal Cancer Oncogene Krüppel-like Factor 5 Expression by Ultrahigh-Throughput Screening Molecular Cancer Therapeutics ·Agnieszka B. Bialkowska, Melissa Crisp, Thomas D. Bannister, Yuanjun He, Sarwat Chowdhury, Stephan C. Schürer, Peter Chase, Timothy Spicer, Franck Madoux, Chenlu Tian, Peter Hodder, Daniel Zaharevitz, Vincent W. Yang	2011	37
17	Identification of Verrucarin A as a Potent and Selective Steroid Receptor Coactivator-3 Small Molecule Inhibitor PLoS ONE ·Fei Yan, Yang Yu, Dar‐Chone Chow, Timothy Palzkill, Franck Madoux, Peter Hodder, Peter Chase, Patrick R. Griffin, Bert W. O’Malley, David M. Lonard	2014	37
18	Collection and Recruitment of CD34+ Cells During Large-Volume Leukapheresis Journal of Hematotherapy ·Gavin Cull, John Ivey, Peter Chase, ROSANNA PICCIUTO, R.P. Herrmann, Paul Cannell	1997	35
19	First-in-Class Inhibitors of Sulfur Metabolism with Bactericidal Activity against Non-ReplicatingM. tuberculosis ACS Chemical Biology ·Prakash B. Palde, Ashima Bhaskar, Laura E. Pedró Rosa, Franck Madoux, Peter Chase, Vinayak Gupta, Timothy Spicer, Louis Scampavia, Amit Singh, Kate S. Carroll	2015	35
20	Discovery, synthesis and SAR analysis of novel selective small molecule S1P4-R agonists based on a (2Z,5Z)-5-((pyrrol-3-yl)methylene)-3-alkyl-2-(alkylimino)thiazolidin-4-one chemotype Bioorganic & Medicinal Chemistry Letters ·Mariangela Urbano, Miguel Guerrero, Subash Velaparthi, Melissa Crisp, Peter Chase, Peter Hodder, Marie‐Therese Schaeffer, Steven J Brown, Hugh Rosen, Edward Roberts	2011	31

About Peter Chase

Peter Chase is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Oncology, Cell Biology and Organic Chemistry, having authored 69 papers that have together received 2.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (8 papers), Neuroscience and Neuropharmacology Research (7 papers), Peptidase Inhibition and Analysis (6 papers), Sphingolipid Metabolism and Signaling (5 papers), Computational Drug Discovery Methods (5 papers), Ubiquitin and proteasome pathways (4 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Physiology (124 citations), Molecular Biology (1.2k citations), Cell Biology (283 citations), Sensory Systems (66 citations) and Computational Theory and Mathematics (249 citations). Peter Chase has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Peter Hodder, Timothy Spicer, Franck Madoux, Hugh Rosen, S. Adrian Saldanha, Dmitriy Minond, Craig W. Lindsley, Patrick R. Griffin, Frank J. Schoenen and Patrick Porubsky. Their work appears in journals such as SLAS DISCOVERY, Bioorganic & Medicinal Chemistry Letters, Assay and Drug Development Technologies, ACS Chemical Biology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Peter Chase

Impact in

Papers in i

In The Last Decade

Peter Chase

Peers

Countries citing papers authored by Peter Chase

Fields of papers citing papers by Peter Chase

All Works

About Peter Chase

Explore authors with similar magnitude of impact

Papers in